MIRA Pharmaceuticals, Inc.
MIRAHealthcare|Drug Manufacturers - General|US
$0.57
+0.03 (+5.61%)
DCF Value
$0.26
Tangible Book / Share
$0.19
Cash / Share
$0.19
Clinical Trials (7)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05780151 Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL) | Diabetes Mellitus, Type 2 | P4 | Completed | 107 | RCT, Open-label | Toujeo |
| NCT07791303 Safety, Tolerability and Pharmacokinetics of Oral Ketamir-2 in Healthy Adult Subjects | Healthy Adult Participants | P1 | Completed | 57 | Double-blind | Ketamir-2, Placebo |
| NCT05883787 Development of a Technical Solution to Digitalize the Analysis of Failure and Effects. | Notification, Spousal | Withdrawn | — | — | — | |
| NCT05818631 Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer | Prostate Cancer, Prostate Cancer Diagnosis | Unknown | 300 | — | — | |
| NCT07823673 Comparing Pain Science Education to Biomedical Education for People With Knee Osteoarthritis: A Randomized Controlled Trial | Knee Arthritis Osteoarthritis | N/A | Not Yet Recruiting | 82 | RCT, Open-label | — |
| NCT06167252 Map of Unwanted Loneliness | Loneliness | Completed | 992 | — | — | |
| NCT05614271 Chronic Postsurgical Pain, Postoperative Cognitive Dysfunction and Resilience | Postoperative Cognitive Dysfunction, Chronic Post Operative Pain | Unknown | 100 | — | — |